Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000727644 | SCV000854933 | uncertain significance | not provided | 2017-09-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001304517 | SCV001493802 | benign | Bethlem myopathy 1A | 2024-08-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002533079 | SCV003717752 | uncertain significance | Inborn genetic diseases | 2022-06-24 | criteria provided, single submitter | clinical testing | The c.2797G>A (p.G933S) alteration is located in exon 35 (coding exon 35) of the COL6A1 gene. This alteration results from a G to A substitution at nucleotide position 2797, causing the glycine (G) at amino acid position 933 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV000727644 | SCV003833817 | uncertain significance | not provided | 2021-06-22 | criteria provided, single submitter | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV000727644 | SCV001800287 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000727644 | SCV001972032 | likely benign | not provided | no assertion criteria provided | clinical testing |